---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-028300"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2022-10-13T23:59:59+00:00"
generated_at: "2026-06-23T03:47:53.285495+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics closes $5.1M public offering of 3.78M units at $1.35/unit

## Summary
- Gross proceeds of $5.1M from offering of 3,777,778 units at $1.35 per unit.
- Each unit includes one common share and three Series A, B, C warrants exercisable at $1.62, $1.35, $2.16 respectively.
- Warrants expire five years from issuance; Series C warrants eligible for cashless exercise upon $10M volume trigger.
- Net proceeds to fund clinical trials, patent portfolio, CRO retention, and working capital.
- WallachBeth Capital acted as sole book-runner; over-allotment option partially exercised for 556,037 warrants.

## SEC filing metadata
- accession: 0001493152-22-028300
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2022-10-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315222028300/0001493152-22-028300-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315222028300/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-028300
- JSON: https://secwatch.observer/filing/0001493152-22-028300.json
- Plain text: https://secwatch.observer/filing/0001493152-22-028300.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.